RECURRENT MENINGIOMA
Clinical trials for RECURRENT MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MENINGIOMA trials appear
Sign up with your email to follow new studies for RECURRENT MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for brain tumor patients: targeted drugs aim to halt meningioma growth
Disease control Recruiting nowThis study tests four drugs (vismodegib, GSK2256098, capivasertib, abemaciclib) in 124 adults with progressive meningiomas that have certain gene mutations. The goal is to see if these targeted therapies can stop or slow tumor growth. Participants must have a confirmed meningioma…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 04:28 UTC
-
Radioactive drug targets Hard-to-Treat brain tumors
Disease control Recruiting nowThis study tests a radioactive drug called Lutathera for people with a type of brain tumor called meningioma that cannot be surgically removed and has grown after radiation therapy. The drug is given through a vein and aims to kill tumor cells. About 42 participants will be enrol…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New hope for Hard-to-Treat brain tumors: targeted radiation trial launches
Disease control Recruiting nowThis study tests a new treatment for people with recurrent meningioma, a type of brain tumor that has come back after surgery or radiation. The treatment uses a radioactive drug called 177Lu-DOTATATE, which targets tumor cells and delivers radiation directly to them. About 136 ad…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New radiation approach may improve tumor control for brain tumor patients
Disease control Recruiting nowThis study tests a new radiation technique called hypofractionated stereotactic radiosurgery for people with grade II or recurrent grade I meningiomas after surgery. The treatment delivers higher doses of radiation over fewer sessions to kill remaining tumor cells while reducing …
Matched conditions: RECURRENT MENINGIOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 22, 2026 13:52 UTC